Flex Pharma (FLKS) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Flex Pharma Reports Second Quarter 2017 Financial Results
August 2, 2017 7:30 AM EDT
-- FLX-787 Granted Fast Track Designation for ALS --
--
US Phase 2 ALS Trial Initiated under IND --
-- US Phase 2
CMT Trial Commencing Third Quarter --
Conference Call
Scheduled Today at 8:45 a.m. ET
BOSTON--(BUSINESS WIRE)-- Click to Tweet
... More
